Clinical Trial on Entocid Chewable Tablet for Hyperacidity and Gastroesophageal Reflex Disease
Abstract
Objective: To investigate the therapeutic effects of the herbal medication Entocid chewable Tablet a product of Herbion pharmaceutical on the indications and gastric motility of patients with hyperacidity and gastro esophageal reflux disease (GERD).
Methods: Total 50 patient were selected for this study. The patients were selected using a modified Reflux Disease Questionnaire, which is a validated, self-administered scale that is widely used for the assessment of anti-reflux treatment effects. Patients were advised to take study medicine 2 tablets twice daily after meal for 1 week. We take follow up after 1 week. We select the subjects from Sharafi Goth Govt. Hospital Naik Muhamamd Dispensary.
Results: Entocid Chewable tablets were innocuous and well endured and compact the occurrences of all the evaluated GERD symptoms, with no adverse events requiring withdrawal.
Conclusion: Entocid chewable tablets may provide a harmless and active management for decreasing the symptoms of GERD.
Submitting a manuscript to a journal implies that the work has not previously been published in any other journal, printed or online (save as an abstract or an academic thesis), and that it is not currently being considered for publication elsewhere.
